Floatz logo

Cyclosporin A

Fungal Infectious Disease

Stanford Universityprotein_peptidePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Fungal Infectious Disease cohort.

Asset / SponsorPhaseRating
Caspofungin
Texas Tech University Health Sciences Center
Phase 4BBB
Posaconazole
Bochud Pierre-Yves
Phase 4BB
Anidulafungin
Texas Tech University Health Sciences Center
Phase 4BB
SUBA-ITRACONAZOLE COMPONENT ITRACONAZOLE
Samsung Medical Center
Phase 4BB
Fluconazole
Bochud Pierre-Yves
Phase 3BB
L-Ofloxacin
Children's Oncology Group
Phase 3BB
Voriconazole
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 3B
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit
Stanford University
Phase 2B

Same molecule, other indications

Cyclosporin A is also rated in:

non-Hodgkin lymphomaActive
BBB
Indicative · Phase 3
76 / 100
View asset →
myelodysplastic/myeloproliferative neoplasmActive
BBB
Indicative · Phase 3
76 / 100
View asset →
disease related to transplantationActive
BBB
Indicative · Phase 4
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →